- Home
- FF vs NKTR Comparison
FF vs NKTR Comparison
Compare FF & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FF
- NKTR
- Stock Information
- Founded
- FF N/A
- NKTR 1990
- Country
- FF United States
- NKTR United States
- Employees
- FF N/A
- NKTR N/A
- Industry
- FF Major Chemicals
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- FF Industrials
- NKTR Health Care
- Exchange
- FF Nasdaq
- NKTR Nasdaq
- Market Cap
- FF 180.0M
- NKTR 160.4M
- IPO Year
- FF N/A
- NKTR 1994
- Fundamental
- Price
- FF $4.12
- NKTR $0.59
- Analyst Decision
- FF Strong Buy
- NKTR Strong Buy
- Analyst Count
- FF 1
- NKTR 6
- Target Price
- FF $0.80
- NKTR $4.92
- AVG Volume (30 Days)
- FF 268.1K
- NKTR 2.2M
- Earning Date
- FF 05-12-2025
- NKTR 05-08-2025
- Dividend Yield
- FF 5.83%
- NKTR N/A
- EPS Growth
- FF N/A
- NKTR N/A
- EPS
- FF 0.35
- NKTR N/A
- Revenue
- FF $243,339,000.00
- NKTR $87,248,000.00
- Revenue This Year
- FF N/A
- NKTR N/A
- Revenue Next Year
- FF N/A
- NKTR N/A
- P/E Ratio
- FF $11.66
- NKTR N/A
- Revenue Growth
- FF N/A
- NKTR N/A
- 52 Week Low
- FF $3.77
- NKTR $0.43
- 52 Week High
- FF $6.40
- NKTR $1.93
- Technical
- Relative Strength Index (RSI)
- FF 52.30
- NKTR 39.04
- Support Level
- FF $3.91
- NKTR $0.57
- Resistance Level
- FF $4.19
- NKTR $0.81
- Average True Range (ATR)
- FF 0.12
- NKTR 0.06
- MACD
- FF 0.02
- NKTR -0.01
- Stochastic Oscillator
- FF 74.11
- NKTR 7.48
About FF FutureFuel Corp. Common shares
FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.